Pharmacy benefit managers (PBMs) “invent all these special categories,” Cuban told Fortune’s Andrew Nusca. “They’re just ...

At the Fortune Brainstorm Tech Dinner Mark Cuban discusses his efforts to disrupt the pharmaceutical industry through Cost Plus Drugs, focusing on transparency in pricing and lowering drug costs.

Plus Oceans Healthcare adds five states with acquisition and UTA professor leads $1.8 million study.

CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging margins.

Mark Cuban is game to chat on social media—just not necessarily on X, formerly Twitter, he told the Fortune Brainstorm ...

As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...

Roughly a year after selling much of his stake in the Mavs to Miriam Adelson and her family, Cuban has been reflecting on his ...

Nearly three years after its launch, Mark Cuban Cost Plus Drug Co. now manufactures injectables in shortage, works with thousands of healthcare facilities, including pharmacies, hospitals ...

The nonprofit health system’s new partnership with the Mark Cuban Cost Plus Drug Co. marketplace for businesses officially goes into effect in January. The marketplace is part of Cuban’s larger ...

Bipartisan bills in Congress would rein them in. And businesses such as Mark Cuban’s Cost Plus Drugs and smaller, “transparent PBMs” have tried to wean pharmaceutical companies and health plans from ...

Cuban has taken issue with Meta CEO Mark Zuckerberg and his proposal to work closely with President-elect Donald Trump ...

Penn Medicine has enlisted Mark Cuban Cost Plus Drug Company to secure key generics for its retail pharmacy network. Penn will lean on the Cost Plus Marketplace for 100 of the most frequently ...